Search alternatives:
ppm decrease » a decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
ppm decrease » a decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
-
1
-
2
-
3
-
4
Top 15 predictors in the ML model for IHD based on mean decrease accuracy.
Published 2024“…<p>Top 15 predictors in the ML model for IHD based on mean decrease accuracy.…”
-
5
Top 15 predictors in the ML model for AMI based on mean decrease accuracy.
Published 2024“…<p>Top 15 predictors in the ML model for AMI based on mean decrease accuracy.…”
-
6
Mean decrease in accuracy (MDA) of top 15 urine metabolites.
Published 2020“…<p>MDA of the top 15 urine metabolites for the discrimination of meloxicam-treated (n = 5) and saline-controls (n = 6) for each time points (2–5) after the administration of meloxicam derived from random forest analysis. …”
-
7
-
8
-
9
-
10
-
11
-
12
Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20